Use of Bridge-1 and activators and inhibitors thereof in the...

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S093210

Reexamination Certificate

active

07875275

ABSTRACT:
The present invention is directed to the use of Bridge-1 polynucleotides and Bridge-1 polypeptides, as well as activators and inhibitors of Bridge-1 activity, in the treatment of Bridge-1 mediated disorders, including diabetes.

REFERENCES:
patent: 4690918 (1987-09-01), Beppu et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: WO 93/25234 (1993-12-01), None
patent: WO 94/06920 (1994-03-01), None
patent: WO 0065052 (2000-11-01), None
Thomas et al. Mol. & Cell. Bio., 19(12): 8492-8504, Dec. 1999.
Thomas et al. Mol. And Cell. Bio., 19(12): 8492-8504, 1999.
Ahlgren, U., et al., “β-Cell-specific inactivation of the mouse Ipfl/Pdxl gene results in loss of the β-cell phenotype and maturity onset diabetes,”Genes Dev12: 1763-1768, Cold Spring Harbor Laboratory Press, US (1998).
Alt, M. and Caselmann, W.H., “Liver-directed gene therapy: molecular tools and current preclinical and clinical studies,”J Hepatol23: 746-758, Elsevier, UK (1995).
Andreassen, O.A., et al., “Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression,”Neurobiol Dis11: 410-424, Elsevier Sience, US (2003).
Antinozzi, P.A., et al., “Metabolic Engineering with Recombinant Adenoviruses,”Annu Rev Nutr19: 511-544, Annual Reviews, US (1999).
Asahara, H., et al. “Pbx-Hox Heterodimers Recruit Coactivator-Corepressor Complexes in an Isoform-Specific Manner,”Mol Cell Biol19(12): 8219-8225, American Society for Microbiology, US (1999).
Berkner, K.L., “Development of Adenovirus Vectors for the Expression of Heterologous Genes,”Bio Techniques6(7): 616-629, Informa BioSciences, US (1988).
Ahlgren, U., et al., “β-Cell-specific inactivation of the mouseIpf1/Pdx1gene results in loss of the β-cell phenotype and maturity onset diabetes,”Genes Dev12: 1763-1768, Cold Spring Harbor Laboratory Press, US (1998).
Brody, S.L. and Crystal, R.G., “Adenovirus-Mediated in Vivo Gene Transfer,”Ann NY Acad Sci716: 90-101, New York Academy of Sciences, US (1994).
Brü{umlaut over (,)}ning, J.C., et al., “Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous forIRandIRS-1Null Alleles,”Cell88: 561-572, Cell Press, US (1997).
Butler, A.E., et al., “Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes,”Diabetes52: 2304-2314, American Diabetes Association, US (2003).
Chakrabarti, S.K., et al., “Covalent Histone Modifications Underlie the Developmental Regulation of Insulin Gene Transcription in Pancreatic β Cells,”J Biol Chem278(26): 23617-23623, The American Society for Biochemistry and Molecular Biology, US (2003).
Chan, H.M. and La Thangue, N.B., “p300/CBP proteins: HATs for transcriptional bridges and scaffolds,”J Cell Sci114: 2363-2373, The Company of Biologists Ltd, UK (2001).
Chen, J., et al., “Role of Akt/protein kinase B in the activity of transciptional coactivator p300,”Cell Mol Life Sci61: 1675-1683, Birkhäuser Verlag, DE (2004).
Chen, S., et al., “Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo,”Proc Natl Acad SciUSA 91: 3054-3057, National Academy of Science, US (1994).
Conaway, R.C., et al., “Emerging Roles of Ubiquitin in Transcription Regulation,”Science296: 1254-1258, American Association for the Advancement of Science, US (2002).
Demartino, G.N., et al., “Identification, Purification, and Characterization of a PA700-dependent Activator of the Proteasome,”J Biol Chem271(6): 3112-3118, The American Socitey for Biochemistry and Molecular Biology, Inc., US (1996).
Donath, M.Y. And Halban, P.A., “Decreased beta-cell mass in diabetes: significance, mechanisms, and therapeutic implications,”Diabetologia47: 581-589, Springer-Verlag, DE (2004).
Dor, Y., et al., “Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation,”Nature429: 41-46, Nature Publishing Group, UK (2004).
Edgar, B.A., “From small flies come big discoveries about size control,”Nat Cell Biol7: E191-E193, Macmillan Magazines Ltd, UK (1999).
Eeckhoute, J., et al., “Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4α (HNF4α) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator,”Mol Endocrinol15(7): 1200-1210, The Endocrine Society, US (2001).
Ehm, M.G., et al., “Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations,”Am J Hum Genet66: 1871-1881, The American Society of Human Genetics, US (2000).
Etienne-Julan, M., et al., “The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker,”J Gen Virol73: 3251-3255, SGM, UK (1992).
Fajans, S.S., et al., “Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young,”N Engl J Med345(13): 971-980, Massachusetts Medical Society, US (2001).
Ferry, N. and Heard, J.M., “Liver-Directed Gene Transfer Vectors,”Hum Gene Ther9: 1975-1981, Mary Ann Liebert, Inc., US (1998).
Flotte, T.R., et al., “Expression of the Cystic Fibrosis Transmembrane Conductance Regulator from a Novel Adeno-associated Virus Promoter,”J Biol Chem268(5): 3781-3790, The American Society for Biochemistry and Molecular Biology, Inc., US (1993).
Flotte, T.R., et al., “Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells,”Am J Respir Cell Mol Biol7: 349-356, American Thoratic Society, US (1992).
Frayling, T.M., et al., “A Genome-Wide Scan in Families With Maturity-Onset Diabetes of the Young,”Diabetes52: 872-881, American Diabetes Association, US (2003).
Gerich, J.E., “Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus,”Mayo Clin Proc78: 447-456, Mayo Foundation for Medical Education and Research, US (2003).
Giles, R.H., et al., “Conjunction dysfunction: CBP/p300 in human disease,”TIG14(5): 178-83, Elsevier Science Ltd, UK (1998).
Gonzalez, F., et al., “Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter,”Science296: 548-550, American Association for the Advancement of Science, US (2002).
Goud, B., et al., “Antibody-Mediated Binding of a Murine Ecotropic Moloney Retroviral Vector to Human Cells Allows Internalization But Not the Establishment of the Proviral State,”Virol163: 251-254, Academic Press, Inc., US (1988).
Graham, F.L. and Prevec, L., “Manipulation of Adenovirus Vectors,” inMethods in Molecular Biology, E.J. Murray, Ed., vol. 7, pp. 109-127, Humana, Clifton N.J., 1991.
Grossman, S.R., et al., “p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation,”Mol Cell2: 405-415, Cell Press, US (1998).
Grossman, S.R., et al., “Polyubiquination of p53 by a Ubiquitin Ligase Activity of p300,”Science300: 342-344, American Association for the Advancement of Science, US (2003).
Haj-Ahmad, Y., et al., “Development of a Helper-Independent Human Adenovirus Vector and Its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene,”J Virol57(1): 267-274, American Society for Microbiology, US (1986).
Hara, K., et al., “A genetic variation in thePGC-1gene could confer insulin resistance and susceptibility to Type II diabetes,”Diabetologia45: 740-743, Springer-Verlag, DE (2002).
Hermonat, P.L., et al., “Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells,”Proc Natl Acad Sci USA81: 6466-6470, National Academy of Science, US (1984).
Hussain

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of Bridge-1 and activators and inhibitors thereof in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of Bridge-1 and activators and inhibitors thereof in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Bridge-1 and activators and inhibitors thereof in the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2725052

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.